Literature DB >> 6181651

Effect of human leukocyte interferon on phagocytic activity of polymorphonuclear leukocytes.

K Melby, T Midtvedt, M Degré.   

Abstract

The effect of homologous leukocyte interferon HuIFN on the phagocytic activity of human polymorphonuclear (PMN) leukocytes was examined. The PMN cells were obtained from healthy donors and they were grown on coverslips. Escherichia coli labelled with 32P-orthophosphate was phagocytized in the presence of fresh homologous serum during a 15 min incubation period. PMN cells pretreated with interferon for at least 3 hours ingested more bacteria as compared to untreated controls. This effect was dose dependent, in maximal effect being obtained with 10(3) units per ml. The effect was species specific and it was neutralized by antiinterferon globulin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181651     DOI: 10.1111/j.1699-0463.1982.tb00102.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  5 in total

1.  Modulation of granulocyte oxidative response by recombinant interferon alpha 2 and gamma.

Authors:  A Kapp; H Kirchner; H Wokalek; E Schöpf
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Human polymorphonuclear neutrophil functions are unaffected by human interferon-alpha 2.

Authors:  B Farr; J M Gwaltney; F G Hayden; G L Mandell
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

3.  Beta-glucuronidase release from leukocytes in children.

Authors:  M Rister; U Nett
Journal:  Klin Wochenschr       Date:  1985-06-18

4.  Effect of interferon on human neutrophilic granulocytes.

Authors:  C Jarstrand; S Einhorn
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 5.  Multiple Phenotypic Changes Define Neutrophil Priming.

Authors:  Irina Miralda; Silvia M Uriarte; Kenneth R McLeish
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.